高剂量静脉注射环丙沙星在青年、老年以及男性和女性受试者中的药代动力学。
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects.
作者信息
Shah A, Lettieri J, Nix D, Wilton J, Heller A H
机构信息
Miles Inc., West Haven, Connecticut 06516, USA.
出版信息
Antimicrob Agents Chemother. 1995 Apr;39(4):1003-6. doi: 10.1128/AAC.39.4.1003.
Abstract
The effects of age and gender on the pharmacokinetics of high-dose intravenous ciprofloxacin in a healthy volunteer study were investigated. Plasma ciprofloxacin concentrations were higher in the elderly than in the young, and the pharmacokinetic parameters were not significantly different between the genders. Ciprofloxacin was well tolerated, with the majority of adverse events related to local reactions at the IV site.
摘要
在一项健康志愿者研究中，调查了年龄和性别对大剂量静脉注射环丙沙星药代动力学的影响。老年受试者血浆中环丙沙星浓度高于年轻受试者，且药代动力学参数在不同性别之间无显著差异。环丙沙星耐受性良好，大多数不良事件与静脉注射部位的局部反应有关。
相似文献
1
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects.高剂量静脉注射环丙沙星在青年、老年以及男性和女性受试者中的药代动力学。
Antimicrob Agents Chemother. 1995 Apr;39(4):1003-6. doi: 10.1128/AAC.39.4.1003.
2
Ciprofloxacin in critically ill subjects: considering hepatic function, age and sex to choose the optimal dose.危重症患者中的环丙沙星：考虑肝功能、年龄和性别选择最佳剂量。
J Antimicrob Chemother. 2019 Mar 1;74(3):682-690. doi: 10.1093/jac/dky485.
3
Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400-mg intravenous doses.环丙沙星200毫克、300毫克和400毫克静脉给药后的剂量范围药代动力学研究。
Ann Pharmacother. 1992 Jan;26(1):8-10. doi: 10.1177/106002809202600101.
4
[Pharmacokinetics of ciprofloxacin injection in healthy volunteers].
Hua Xi Yi Ke Da Xue Xue Bao. 1995 Sep;26(3):315-8.
5
Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration.环丙沙星在年轻（健康志愿者）和老年患者中的药代动力学，以及静脉给药后前列腺液、精液和前列腺腺瘤组织中的浓度。
Am J Med. 1989 Nov 30;87(5A):57S-59S. doi: 10.1016/0002-9343(89)90023-5.
6
Influence of age on the pharmacokinetics of ciprofloxacin.
Scand J Infect Dis Suppl. 1989;60:23-7.
7
Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.吸入用环丙沙星干粉在囊性纤维化患者中的耐受性和药代动力学特征：一项 I 期、随机、剂量递增研究。
Clin Ther. 2013 Oct;35(10):1571-81. doi: 10.1016/j.clinthera.2013.08.003. Epub 2013 Sep 18.
8
Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.氧氟沙星和环丙沙星静脉注射的比较药代动力学。
J Antimicrob Chemother. 1988 Sep;22 Suppl C:73-9. doi: 10.1093/jac/22.supplement_c.73.
9
Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):515-20. doi: 10.1007/BF01967470.
10
Pharmacokinetics of intravenous ciprofloxacin at three different doses.
J Antimicrob Chemother. 1988 Nov;22(5):715-20. doi: 10.1093/jac/22.5.715.
引用本文的文献
1
The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells.环丙沙星对多柔比星耐药的 DU145 前列腺癌细胞中多柔比星细胞毒性的影响。
Med Oncol. 2022 Sep 7;39(12):194. doi: 10.1007/s12032-022-01787-9.
2
Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study.接受体外膜肺氧合（ECMO）治疗患者的环丙沙星：一项群体药代动力学研究。
Pharmaceutics. 2022 Apr 29;14(5):965. doi: 10.3390/pharmaceutics14050965.
3
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.一个描述环丙沙星药代动力学在整个生命周期内的生理基于药代动力学模型。
Clin Pharmacokinet. 2018 Dec;57(12):1613-1634. doi: 10.1007/s40262-018-0661-6.
4
Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.应用基于生理的药代动力学模型研究茶碱代谢及其与环丙沙星和咖啡因的相互作用。
CPT Pharmacometrics Syst Pharmacol. 2016 Feb;5(2):74-81. doi: 10.1002/psp4.12061. Epub 2016 Feb 16.
5
Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary disease.环丙沙星的药代动力学及其在慢性阻塞性肺疾病机械通气患者支气管分泌物中的渗透。
Antimicrob Agents Chemother. 2011 Sep;55(9):4149-53. doi: 10.1128/AAC.00566-10. Epub 2011 Jun 13.
6
Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.环丙沙星耐药金黄色葡萄球菌在体外药代动力学环境中的演变。
Antimicrob Agents Chemother. 2004 Dec;48(12):4733-44. doi: 10.1128/AAC.48.12.4733-4744.2004.
7
Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group.高剂量静脉注射环丙沙星在严重脓毒症中的药代动力学特征。巴拉圭纳特环丙沙星研究小组。
Antimicrob Agents Chemother. 1998 Sep;42(9):2235-9. doi: 10.1128/AAC.42.9.2235.
8
Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.健康受试者单次口服500毫克左氧氟沙星的药代动力学不存在年龄和性别影响。
Antimicrob Agents Chemother. 1997 Jul;41(7):1562-5. doi: 10.1128/AAC.41.7.1562.
9
Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects.两种新型氟喹诺酮类药物巴洛沙星和格帕沙星在老年受试者体内的药代动力学比较研究。
Antimicrob Agents Chemother. 1996 Dec;40(12):2824-8. doi: 10.1128/AAC.40.12.2824.
10
Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers.口服氟罗沙星在男性和绝经前女性志愿者体内的药代动力学。
Antimicrob Agents Chemother. 1996 Mar;40(3):789-91. doi: 10.1128/AAC.40.3.789.
本文引用的文献
1
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.住院患者重症肺炎的治疗：一项比较静脉注射环丙沙星与亚胺培南 - 西司他丁的多中心、随机、双盲试验结果。重症肺炎研究组
Antimicrob Agents Chemother. 1994 Mar;38(3):547-57. doi: 10.1128/AAC.38.3.547.
2
Noncompartmental determination of the steady-state volume of distribution during multiple dosing.多次给药期间稳态分布容积的非房室测定
J Pharm Sci. 1984 Feb;73(2):281-2. doi: 10.1002/jps.2600730239.
3
Dose- and sex-independent disposition of ciprofloxacin.
Eur J Clin Microbiol. 1984 Aug;3(4):363-6. doi: 10.1007/BF01977496.
4
Absolute oral bioavailability of ciprofloxacin.环丙沙星的绝对口服生物利用度。
Antimicrob Agents Chemother. 1986 Sep;30(3):444-6. doi: 10.1128/AAC.30.3.444.
5
Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.
J Antimicrob Chemother. 1986 May;17(5):629-35. doi: 10.1093/jac/17.5.629.
6
Pharmacokinetics of ciprofloxacin in elderly subjects.
Pharmacotherapy. 1986 Mar-Apr;6(2):87-91. doi: 10.1002/j.1875-9114.1986.tb03458.x.
7
Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):515-20. doi: 10.1007/BF01967470.
Zotero 插件